Is WLLW.TO stock a buy on the current oversold bounce?

WLLW.TO stock is a short-term oversold bounce candidate, not a broad buy recommendation. High relative volume and price below moving averages support a bounce trade, but negative EPS and tiny market cap demand small position sizes and strict stops.

What price targets should traders use for WLLW.TO stock?

Meyka AI models a conservative short-term bounce target at **C$0.10** and an optimistic rebound at **C$0.25** from the current **C$0.035**. These are projections, not guarantees, and traders should use stops and size positions accordingly.

How does WLLW.TO stock compare to peers in the healthcare sector?

WLLW.TO stock trades far below book value with a P/B of **0.03**, differing from larger sector peers that show higher PB and steadier revenue. The healthcare sector shows mixed performance and negative average ROA, making peer comparison essential for context.

Where can I find official company information for WLLW.TO stock?

Official filings and company news are available on the Willow Biosciences website. See the corporate site: [Willow Biosciences](https://www.willowbio.com) and investor pages for press releases and financial statements.

CA Stocks

WLLW.TO Willow Biosciences TSX C$0.035 Pre-Mkt Mar 2026: Oversold bounce watch

ByHuzaifa Zahoor March 10, 2026March 10, 2026

WLLW.TO stock trades at C$0.035 in pre-market activity on the TSX, setting up a classic oversold bounce candidate. Volume today is elevated at 3,804,082 shares versus an average of 144,583, producing a relative volume of 26.31. That surge shows short-term interest after a steep run from year lows and heavy decay versus the 50-day C$0.1406 and 200-day C$0.2514 averages. Traders using an oversold bounce strategy should weigh the potential rebound against weak earnings and tight liquidity on this Canada-listed healthcare microcap.